慢性副鼻腔炎を病態から考える 2型炎症を見逃さない

Saved in:
Bibliographic Details
Published in日本耳鼻咽喉科免疫アレルギー感染症学会誌 Vol. 5; no. 1; pp. 49 - 52
Main Authors 近松, 一朗, 松山, 敏之
Format Journal Article
LanguageJapanese
Published 日本耳鼻咽喉科免疫アレルギー感染症学会 2025
Subjects
Online AccessGet full text
ISSN2435-7952
DOI10.24805/jiaio.5.1_49

Cover

Author 近松, 一朗
松山, 敏之
Author_xml – sequence: 1
  fullname: 近松, 一朗
  organization: 群馬大学大学院医学系研究科耳鼻咽喉科・頭頸部外科
– sequence: 1
  fullname: 松山, 敏之
  organization: 群馬大学大学院医学系研究科耳鼻咽喉科・頭頸部外科
BookMark eNo9j8tKw0AYhQdRsNYufQkh8Z9bkgE3UrxBwU33w5-ZiSbUVpJu3LWRgCXgQgT3blz6APo2wbS-hUXFA4cPzuKDs0M2x5OxI2SPgs9EBPIgSzGd-NKnWqgN0mGCSy9Ukm2TXlGkMUgIeUCBd8h-W720s9fPxdvXx_uqelqWD035uHyu2qpu5nVTLlazu2Z-35T1LtlKcFS43h-7ZHhyPOyfeYOL0_P-0cDLKBfoJYpJ48IkpNZZsMpGMVJYJ-I0YTxwBtCw0CaAyEFELAYmqLIYsSCWhnfJ4a82K6Z46fRNnl5jfqsxn6Zm5PTPNy01XVeo_9lcYa4z5N-uUFr2
ContentType Journal Article
Copyright 2025 日本耳鼻咽喉科免疫アレルギー感染症学会
Copyright_xml – notice: 2025 日本耳鼻咽喉科免疫アレルギー感染症学会
DOI 10.24805/jiaio.5.1_49
DeliveryMethod fulltext_linktorsrc
EISSN 2435-7952
EndPage 52
ExternalDocumentID article_jiaio_5_1_5_49_article_char_ja
GroupedDBID JSF
RJT
ID FETCH-LOGICAL-j134a-f925ce7f71ded0d9d8ba10000831f236ec0ac27df0aa30482b02419da826b5c3
IngestDate Wed Sep 03 06:30:47 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 1
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j134a-f925ce7f71ded0d9d8ba10000831f236ec0ac27df0aa30482b02419da826b5c3
OpenAccessLink https://www.jstage.jst.go.jp/article/jiaio/5/1/5_49/_article/-char/ja
PageCount 4
ParticipantIDs jstage_primary_article_jiaio_5_1_5_49_article_char_ja
PublicationCentury 2000
PublicationDate 2025
PublicationDateYYYYMMDD 2025-01-01
PublicationDate_xml – year: 2025
  text: 2025
PublicationDecade 2020
PublicationTitle 日本耳鼻咽喉科免疫アレルギー感染症学会誌
PublicationTitleAlternate 耳鼻免疫アレルギー感染症
PublicationYear 2025
Publisher 日本耳鼻咽喉科免疫アレルギー感染症学会
Publisher_xml – name: 日本耳鼻咽喉科免疫アレルギー感染症学会
References 2)Tokunaga T, Sakashita M, Haruna T, et al.: Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study. Allergy 2015; 70: 995–1003.
11)Chen M, Guo Z, Ju W, et al.: The development and function of follicular helper T cells in immune responses. Cell Mol Immunol 2012; 9: 375–379.
5)Grayson JW, Cavada M, Harvey RJ: Clinically relevant phenotypes in chronic rhinosinusitis. J Otolaryngol Head Neck Surg 2019; 48: 23.
21)松山敏之,髙橋秀行,多田紘恵,他:好酸球性副鼻腔炎に対するdupilumabの臨床効果.日耳鼻会報 2021; 124: 884–889.
7)Fokkens WJ, Lund VJ, Hopkins C, et al.: European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 2020; 58 (Suppl S29): 1–464.
8)Cao PP, Wang ZC, Schleimer RP, et al.: Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes. Ann Allergy Asthma Immunol 2019; 122: 33–40.
14)Annunziato F, Romagnani C, Romagnani S: The 3 major types of innate and adaptive cell-mediated effector immunity. J Allergy Clin Immunol 2015; 135: 626–635.
19)Salimi M, 1, Stöger L, Liu W, et al.: Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines. J Allergy Clin Immunol 2017; 140: 1090–1100.
4)Stammberger H, Posawetz W: Functional endoscopic sinus surgery. Concept, indications and results of the Messerklinger technique. Eur Arch Otorhinolaryngol 1990; 247: 63–76.
18)Xue L, Salimi M, Panse I, et al.: Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J Allergy Clin Immunol 2014; 133: 1184–1194.
13)Vivier E, Artis D, Colonna M, et al.: Innate lymphoid cells: 10 years on. Cell 2018; 174: 1054–1066.
1)春名眞一,鴻 信義,柳  清,他:好酸球性副鼻腔炎.耳鼻展望 2001; 44: 195–201.
12)Xiong L, Nutt SL, Seillet C: Innate lymphoid cells: More than just immune cells. Front Immunol 2022; 13: 1033904.
10)Ahern S, Cervin A: Inflammation and endotyping in chronic rhinosinusitis-a paradigm shift. Medicina (Kaunas) 2019; 55.
15)鼻副鼻腔炎診療の手引き作成委員会:鼻副鼻腔炎診療の手引き.日鼻科会誌 2024; 63: 1–83.
6)Laidlaw TM, Mullol J, Woessner KM, et al.: Chronic rhinosinusitis with nasal polyps and asthma. J Allergy Clin Immunol Pract 2021; 9: 1133–1141.
17)Kato A: Immunopathology of chronic rhinosinusitis. Allergol Int 2015; 64: 121–130.
20)松山敏之,多田紘恵,近松一朗:鼻茸患者に対するNSAIDsの取り扱い方.耳鼻免疫アレルギー 2019; 37: 229–232.
9)Lou H, Wang C, Zhang L: Endotype-driven precision medicine in chronic rhinosinusitis. Expert Rev Clin Immunol 2019; 15: 1171–1183.
16)Han JK, Bachert C, Fokkens W, et al.: Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med 2021; 9: 1141–1153.
3)藤枝重治,坂下雅文,徳永貴広,他:好酸球性副鼻腔炎 診断ガイドライン(JESREC study).日耳鼻会報 2015; 118: 728–735.
References_xml – reference: 3)藤枝重治,坂下雅文,徳永貴広,他:好酸球性副鼻腔炎 診断ガイドライン(JESREC study).日耳鼻会報 2015; 118: 728–735.
– reference: 16)Han JK, Bachert C, Fokkens W, et al.: Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med 2021; 9: 1141–1153.
– reference: 11)Chen M, Guo Z, Ju W, et al.: The development and function of follicular helper T cells in immune responses. Cell Mol Immunol 2012; 9: 375–379.
– reference: 7)Fokkens WJ, Lund VJ, Hopkins C, et al.: European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 2020; 58 (Suppl S29): 1–464.
– reference: 8)Cao PP, Wang ZC, Schleimer RP, et al.: Pathophysiologic mechanisms of chronic rhinosinusitis and their roles in emerging disease endotypes. Ann Allergy Asthma Immunol 2019; 122: 33–40.
– reference: 9)Lou H, Wang C, Zhang L: Endotype-driven precision medicine in chronic rhinosinusitis. Expert Rev Clin Immunol 2019; 15: 1171–1183.
– reference: 12)Xiong L, Nutt SL, Seillet C: Innate lymphoid cells: More than just immune cells. Front Immunol 2022; 13: 1033904.
– reference: 19)Salimi M, 1, Stöger L, Liu W, et al.: Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines. J Allergy Clin Immunol 2017; 140: 1090–1100.
– reference: 14)Annunziato F, Romagnani C, Romagnani S: The 3 major types of innate and adaptive cell-mediated effector immunity. J Allergy Clin Immunol 2015; 135: 626–635.
– reference: 6)Laidlaw TM, Mullol J, Woessner KM, et al.: Chronic rhinosinusitis with nasal polyps and asthma. J Allergy Clin Immunol Pract 2021; 9: 1133–1141.
– reference: 10)Ahern S, Cervin A: Inflammation and endotyping in chronic rhinosinusitis-a paradigm shift. Medicina (Kaunas) 2019; 55.
– reference: 13)Vivier E, Artis D, Colonna M, et al.: Innate lymphoid cells: 10 years on. Cell 2018; 174: 1054–1066.
– reference: 20)松山敏之,多田紘恵,近松一朗:鼻茸患者に対するNSAIDsの取り扱い方.耳鼻免疫アレルギー 2019; 37: 229–232.
– reference: 17)Kato A: Immunopathology of chronic rhinosinusitis. Allergol Int 2015; 64: 121–130.
– reference: 2)Tokunaga T, Sakashita M, Haruna T, et al.: Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC Study. Allergy 2015; 70: 995–1003.
– reference: 4)Stammberger H, Posawetz W: Functional endoscopic sinus surgery. Concept, indications and results of the Messerklinger technique. Eur Arch Otorhinolaryngol 1990; 247: 63–76.
– reference: 5)Grayson JW, Cavada M, Harvey RJ: Clinically relevant phenotypes in chronic rhinosinusitis. J Otolaryngol Head Neck Surg 2019; 48: 23.
– reference: 1)春名眞一,鴻 信義,柳  清,他:好酸球性副鼻腔炎.耳鼻展望 2001; 44: 195–201.
– reference: 18)Xue L, Salimi M, Panse I, et al.: Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J Allergy Clin Immunol 2014; 133: 1184–1194.
– reference: 15)鼻副鼻腔炎診療の手引き作成委員会:鼻副鼻腔炎診療の手引き.日鼻科会誌 2024; 63: 1–83.
– reference: 21)松山敏之,髙橋秀行,多田紘恵,他:好酸球性副鼻腔炎に対するdupilumabの臨床効果.日耳鼻会報 2021; 124: 884–889.
SSID ssib050736103
ssib045268852
ssj0003322029
Score 2.0053325
SourceID jstage
SourceType Publisher
StartPage 49
SubjectTerms 2型炎症
好酸球性副鼻腔炎
慢性副鼻腔炎
病態
Subtitle 2型炎症を見逃さない
Title 慢性副鼻腔炎を病態から考える
URI https://www.jstage.jst.go.jp/article/jiaio/5/1/5_49/_article/-char/ja
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 日本耳鼻咽喉科免疫アレルギー感染症学会誌, 2025, Vol.5(1), pp.49-52
journalDatabaseRights – providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  databaseCode: M~E
  dateStart: 20210101
  customDbUrl:
  isFulltext: true
  eissn: 2435-7952
  dateEnd: 99991231
  titleUrlDefault: https://road.issn.org
  omitProxy: true
  ssIdentifier: ssib050736103
  providerName: ISSN International Centre
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1R3LbtQwMCrlwgWBAPFWD8wFKUsS27F9dHazqpDgtEi9RXlK3UOLUHvhgNpFK1GtxAEhcefCkQ-A_-ADVmzLXzAeJ8sWOJTekLKRdzwzHnuSzIxjTzzvQdE0gjd15deSFT4XWvmFlKUvyzzEgIjXvLFvdJ88jTef8cdbYmvtwreVVUv7e0WvfPnXfSXn0SrCUK92l-w_aHbJFAFYRv3iGTWM5zPpGNIYlAATUSEAIyEVoDSYIaQakj4kCaTK4mgOqQQVgUohZbagIwvR0tY6PiqhqrArRJaVJQ9Asa5KdVXJql9rOSArQ6x0H0y_JUzYiiTCNpoMqBATc2ll1iGJjceARIrBdALYrjHbumXoCsuqtIUgcys_Bz2k1oegWdc1GhAzABNDyi2mNlYwY0Atp4ctIBmSFEg9gIQWiBI-dcH1SMtf-B0a8k5CexA-QrELQyLU3fi0Eypu2zVd_P_RUDnrTWYi4pR0VJyyaeKPW9fZJ5cetvV0HMnvNjTiKrD5Rsbb-fZuT_TCrCM6lZa8vegzQstEFuKP66wD2z2D2RgDl4uRRBfQrql9lXYPevtZe-U27dN_jEkYuvFsOTnK0MwEkXY5cUmgR6vioLc4xtipW3dJruDoine5jeE2jBPiqrc2zq95DxfTj4uDT9-PPv_4-uVk-v548nY-eXf8YbqYzuaHs_nk6OTg9fzwzXwyu-6Nhumov-m3HyLxxyHjud_oSJS1bGRY1VVQ6UoVOb0XUyxsIhbXZZCXkayaIM8ZmsSoQM831FWOsXshSnbDW9_Z3alvehuNqjGkQaOuVMPDulBxIIsYn4g4CHWc81uecD3LnrtkM9nZxvn2OenueJfsLeDmFO9663sv9ut76GXvFfdJYz8B7yub5A
linkProvider ISSN International Centre
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E6%85%A2%E6%80%A7%E5%89%AF%E9%BC%BB%E8%85%94%E7%82%8E%E3%82%92%E7%97%85%E6%85%8B%E3%81%8B%E3%82%89%E8%80%83%E3%81%88%E3%82%8B&rft.jtitle=%E6%97%A5%E6%9C%AC%E8%80%B3%E9%BC%BB%E5%92%BD%E5%96%89%E7%A7%91%E5%85%8D%E7%96%AB%E3%82%A2%E3%83%AC%E3%83%AB%E3%82%AE%E3%83%BC%E6%84%9F%E6%9F%93%E7%97%87%E5%AD%A6%E4%BC%9A%E8%AA%8C&rft.au=%E8%BF%91%E6%9D%BE%2C+%E4%B8%80%E6%9C%97&rft.au=%E6%9D%BE%E5%B1%B1%2C+%E6%95%8F%E4%B9%8B&rft.date=2025&rft.pub=%E6%97%A5%E6%9C%AC%E8%80%B3%E9%BC%BB%E5%92%BD%E5%96%89%E7%A7%91%E5%85%8D%E7%96%AB%E3%82%A2%E3%83%AC%E3%83%AB%E3%82%AE%E3%83%BC%E6%84%9F%E6%9F%93%E7%97%87%E5%AD%A6%E4%BC%9A&rft.eissn=2435-7952&rft.volume=5&rft.issue=1&rft.spage=49&rft.epage=52&rft_id=info:doi/10.24805%2Fjiaio.5.1_49&rft.externalDocID=article_jiaio_5_1_5_49_article_char_ja